STAT+: Halfway into the year, biotech is booming
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- XBI gained 19% over the past month and is up 30% year-to-date, now trading at 158 — a five-year high
- The biotech benchmark is approaching its February 2021 peak of $175
- June was described as an especially "bonkers" month for biotech sector performance
- The analysis appears in Adam's Biotech Scorecard, a subscriber-only STAT+ newsletter
Why it matters: The XBI's 30% year-to-date gain brings the index to a five-year high of 158, nearly matching its February 2021 peak of $175. A 19% surge in June alone suggests the rally is accelerating heading into the second half, a dramatic reversal for a sector that spent years trading far below those levels.
Ask SkimNews
